HempFusion Corporate Media Kit

6 W W W . H E M P F U S I O N . C O M | H E M P F U S I O N ® P R E S E N T A T I O N 1. COMPLIANCE DRIVEN • HempFusion’s uncompromising approach to regulatory compliance has positioned the Company for potential entry into major retail markets that may be unavailable to other CBD companies, this includes: Large food, drug and mass retail chains (“Food/Drug/Mass” or “Big Box”), Doctor/Practitioner, Convenience and more • The Company has multiple certifications, and executive memberships that take anywhere from 18-24 months to replicate in addition to a significant capital investment • HempFusion is a board member of the US Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products • Ola Lessard, HempFusion’s CMO, is the President of the US Hemp Roundtable 7. IPO & STRONG CASH POSITION • USD $18,315,734 cash as of June 30 th • Second largest cash position in the sector (3) • No debt 2. PROPRIETARY CBD PRODUCT PORTFOLIO • The Company’s diverse product portfolio includes 46 products on the market from tinctures to proprietary FDA Drug Listed Over-The- Counter (“OTC”) Topicals to Doctor/Practitioner Lines and Probulin’s scientifically validated delivery systems • HempFusion Wellness Inc.’s family of brands includes: HempFusion, Probulin Probiotics, Biome Research, and HF Labs 3. RESEARCH & DEVELOPMENT • 30 products under development including OTC Drug Listed Ingestibles and additional topicals • Planned launch of plant-based CBD organic gummies • Human Safety Study (Liver Toxicology 2020) is in progress (1) • Self GRAS Affirmation (October/November 2020 publishing) & NOAEL Safety Review completed for all topicals 4. MULTIPLE REVENUE DRIVERS • FDA Drug Listed OTC Topicals allow access to the largest channel by dollar value; Food/Drug/Mass (Big Box) • Convenience Channel, providing access to significant new sales & distribution opportunities • Products are currently sold in 4,000+ retail locations across 50 states including Sprouts, Vitamin Shoppe, and Fresh Thyme Market • Revenue opportunities from 5 robust channels; Natural, E- commerce, Big Box, Convenience and Doctor Practitioner 6. INTERNATIONAL EXPANSION • HempFusion and Probulin products are planned to be sold across Europe (Ireland & UK) • Probulin has purchase orders and/or is selling in the Middle East, South Korea, China, Mexico, and India • Probulin’s Trojan Horse strategy is a gateway to increased international distribution (2) An innovative & diversified CBD Company powered by proprietary wellness formulations HIGHLIGHTS (1) Please click here for reference (2) Leveraging non-CBD products to achieve approved vendor status (3) Based on available public company presentations and June 30, 2020 Financials 5. BOLSTERED C-SUITE AND BOARD OF DIRECTORS WITH PROVEN AND EXPERIENCED EXECUTIVES • Extensive leadership, public market, finance, legal, CPG and M&A experience are crucial assets in driving the Company’s business plan forward • New additions bring strategic networks, key introductions and a proven ability to execute